Association of venous thromboembolism and myocardial infarction with Factor V Leiden and Factor II gene mutations among Libyan patients
Factor V Leiden G1691A (FVL) and Factor II prothrombin G20210A (PGM) mutations are the
leading causes of thrombophilia. In this study, we have investigated the prevalence of the FVL
G1691A and PGM G20210A single nucleotide polymorphisms (SNPs) among Libyan deep vein
thrombosis (DVT) and myocardial infarction (MI) patients. SNP genotyping was performed
using high-resolution melt analysis (HRM) and DNA sequencing. Biochemical parameters
conducted on 112 males and 93 females showed no significant difference in means between
the control group and the deep vein thrombosis and myocardial infarction groups. For Factor
V Leiden, 40 samples were genotyped. Of the 40 samples, 6 (15.0%) of them were heterozygous
and no one was homozygous. As for Factor II SNP, 59 samples were genotyped and
only 2 (3.3%) were heterozygous. All the heterozygous samples showed 100% concordance
between the HRM-PCR and DNA sequence analysis. Our study showed, for the first time, that
both the FVL and PGM mutations are present among Libyan DVT and MI patients and that the
FVL mutation is significantly associated with DVT but not with MI. However, our results do not
support the association of PGM G20210A mutation with DVT or MI. arabic 18 English 117
Abdulghani Msalati, Abdulla Bashein, Murad Ghrew, Khaled Sedaa, Abushawashi Ali, Ahmed Zaid, (1-2021)